Cargando…

Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept

BACKGROUND: During pelvic Sarcoma resections, Surgeons often struggle to obtain negative margins while minimizing collateral damage and maintaining limb function. These complications are usually due to the complex anatomy of the pelvis. Here we present an accurate 3D surgical approach, including pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Benady, Amit, Gortzak, Yair, Sofer, Summer, Ran, Yuval, Rumack, Netta, Elias, Avital, Efrima, Ben, Golden, Eran, Segal, Ortal, Merose, Omri, Sternheim, Amir, Dadia, Solomon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685900/
https://www.ncbi.nlm.nih.gov/pubmed/36424560
http://dx.doi.org/10.1186/s12891-022-05918-1
_version_ 1784835622312083456
author Benady, Amit
Gortzak, Yair
Sofer, Summer
Ran, Yuval
Rumack, Netta
Elias, Avital
Efrima, Ben
Golden, Eran
Segal, Ortal
Merose, Omri
Sternheim, Amir
Dadia, Solomon
author_facet Benady, Amit
Gortzak, Yair
Sofer, Summer
Ran, Yuval
Rumack, Netta
Elias, Avital
Efrima, Ben
Golden, Eran
Segal, Ortal
Merose, Omri
Sternheim, Amir
Dadia, Solomon
author_sort Benady, Amit
collection PubMed
description BACKGROUND: During pelvic Sarcoma resections, Surgeons often struggle to obtain negative margins while minimizing collateral damage and maintaining limb function. These complications are usually due to the complex anatomy of the pelvis. Here we present an accurate 3D surgical approach, including pre-operative printing of models and intraoperative patient-specific instruments (PSIs) for optimizing pelvic sarcoma resections. METHODS: This single-center retrospective study (N = 11) presents surgical, functional, and oncological outcomes of patients (average age 14.6 +/− 7.6 years, 4 males) who underwent pelvic sarcoma resections using a 3D surgical approach between 2016 and 2021. All patients were followed up for at least 24 months (mean = 38.9 +/− 30.1 months). RESULTS: Our results show promising surgical, oncological, and functional outcomes. Using a 3D approach, 90.9% had negative margins, and 63.6% did not require reconstruction surgery. The average estimated blood loss was 895.45 ± 540.12 cc, and the average surgery time was 3:38 ± 0.05 hours. Our results revealed no long-term complications. Three patients suffered from short-term complications of superficial wound infections. At 24 month follow up 72.7% of patients displayed no evidence of disease. The average Musculoskeletal Tumor Society (MSTS) score at 12 months was 22.81. CONCLUSION: 3D technology enables improved accuracy in tumor resections, allowing for less invasive procedures and tailored reconstruction surgeries, potentially leading to better outcomes in function and morbidity. We believe that this approach will enhance treatments and ease prognosis for patients diagnosed with pelvic sarcoma and will become the standard of care in the future.
format Online
Article
Text
id pubmed-9685900
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96859002022-11-25 Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept Benady, Amit Gortzak, Yair Sofer, Summer Ran, Yuval Rumack, Netta Elias, Avital Efrima, Ben Golden, Eran Segal, Ortal Merose, Omri Sternheim, Amir Dadia, Solomon BMC Musculoskelet Disord Research BACKGROUND: During pelvic Sarcoma resections, Surgeons often struggle to obtain negative margins while minimizing collateral damage and maintaining limb function. These complications are usually due to the complex anatomy of the pelvis. Here we present an accurate 3D surgical approach, including pre-operative printing of models and intraoperative patient-specific instruments (PSIs) for optimizing pelvic sarcoma resections. METHODS: This single-center retrospective study (N = 11) presents surgical, functional, and oncological outcomes of patients (average age 14.6 +/− 7.6 years, 4 males) who underwent pelvic sarcoma resections using a 3D surgical approach between 2016 and 2021. All patients were followed up for at least 24 months (mean = 38.9 +/− 30.1 months). RESULTS: Our results show promising surgical, oncological, and functional outcomes. Using a 3D approach, 90.9% had negative margins, and 63.6% did not require reconstruction surgery. The average estimated blood loss was 895.45 ± 540.12 cc, and the average surgery time was 3:38 ± 0.05 hours. Our results revealed no long-term complications. Three patients suffered from short-term complications of superficial wound infections. At 24 month follow up 72.7% of patients displayed no evidence of disease. The average Musculoskeletal Tumor Society (MSTS) score at 12 months was 22.81. CONCLUSION: 3D technology enables improved accuracy in tumor resections, allowing for less invasive procedures and tailored reconstruction surgeries, potentially leading to better outcomes in function and morbidity. We believe that this approach will enhance treatments and ease prognosis for patients diagnosed with pelvic sarcoma and will become the standard of care in the future. BioMed Central 2022-11-24 /pmc/articles/PMC9685900/ /pubmed/36424560 http://dx.doi.org/10.1186/s12891-022-05918-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Benady, Amit
Gortzak, Yair
Sofer, Summer
Ran, Yuval
Rumack, Netta
Elias, Avital
Efrima, Ben
Golden, Eran
Segal, Ortal
Merose, Omri
Sternheim, Amir
Dadia, Solomon
Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept
title Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept
title_full Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept
title_fullStr Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept
title_full_unstemmed Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept
title_short Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept
title_sort internal hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685900/
https://www.ncbi.nlm.nih.gov/pubmed/36424560
http://dx.doi.org/10.1186/s12891-022-05918-1
work_keys_str_mv AT benadyamit internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT gortzakyair internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT sofersummer internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT ranyuval internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT rumacknetta internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT eliasavital internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT efrimaben internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT goldeneran internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT segalortal internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT meroseomri internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT sternheimamir internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept
AT dadiasolomon internalhemipelvectomyforprimarybonesarcomasusingintraoperativepatientspecificinstrumentsthenextstepinlimbsalvageconcept